Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
18 March 2024 | Story VALENTINO NDABA | Photo SUPPLIED
RIGHT TO VOTE 2024
Expert speakers dissecting South Africa's political landscape at the University of the Free State’s recent panel discussion on the 2024 elections.

The University of the Free State's (UFS) Centre for Gender and Africa Studies (CGAS), in collaboration with the South African Institute of Race Relations (IRR), recently organised an Africa Dialogue Series panel discussion titled ‘Elections 2024: South Africa’s Changing Political Landscape’. The event, held on 6 March 2024, brought together distinguished speakers and experts to dissect the evolving dynamics of South Africa's political landscape as the nation gears up for the 2024 elections.

The panel featured prominent figures including former Tony Leon, Makone Maja, Michael Atkins, and Terence Corrigan, who provided valuable insights into various aspects of the upcoming elections. Prof Heidi Hudson, Professor at the CGAS, expertly moderated the session, ensuring a robust exchange of ideas and perspectives.

Importance of informed dialogue

Prof Hussein Solomon, Senior Professor at CGAS and planner of the dialogue session, reflected on the success of the event in achieving its objectives. He emphasised the importance of informed dialogue in navigating the complex issues surrounding the 2024 elections. "The idea is to inform people of the issues at stake, but also to focus on key issue areas from an academic perspective," Prof Solomon said.

He expressed concerns about voter registration and the need for heightened awareness among youth, underscoring the significance of addressing societal challenges to ensure peaceful elections.

Unprecedented uncertainty in election outcome

Leon, former leader of the Democratic Alliance and a seasoned political analyst, opened the discussion by highlighting the unprecedented uncertainty surrounding the outcome of the 2024 elections. Contrary to previous elections where the victory of the African National Congress (ANC) was almost a given, Leon pointed out that the current political landscape presents a different scenario.

"In all the previous elections we were able to predict an ANC win. This time round it is not that simple," he said. "The ANC will not clear 50 and that’s going to be a big game-changer."

Leon underscored the fragmentation within the ANC itself, noting the emergence of multiple versions of the party with no clear ideological distinctions. He also raised concerns about voter turnout and the implications of a potential government controlled by parties representing a mere fraction of the voting population.

Declining youth political participation

Maja, Campaign Manager at the IRR, shed light on the decline in political participation by youth in South Africa. Drawing from statistical data, she emphasised the need to address the disillusionment among young voters, particularly regarding corruption and unemployment.

"I've been particularly curious about youth for their behaviour," she said. "A lot of the youth... did not align with political parties in South Africa, much more likely in the youth than in the older age categories."

Maja highlighted socioeconomic factors that are contributing to youth disengagement from the political process, and stressed the importance of political engagement in shaping democratic outcomes.

Upholding electoral integrity

Atkins, a seasoned political analyst and independent observer in South African elections, focused on the imperative of upholding electoral integrity. He criticised the flaws in the Electoral Amendment Bill and highlighted concerns about the accuracy of election results.

"We have seen a complete disrespect or even disdain for meaningful electoral reform through these last three years," he said. "Spurious claims of rigging must be objectively and speedily met and countered."

He called for increased transparency and accountability within the electoral process to ensure the legitimacy of election outcomes.

Political dynamics and future scenarios

Corrigan, a Project Manager at the IRR, delved into the changing political dynamics of South Africa and contemplated potential future scenarios. He questioned the sustainability of the dominant party paradigm and examined the possibility of coalition politics in the aftermath of the elections. Corrigan highlighted the emergence of new political players and the implications of coalition politics for stability and governance in South Africa.

The Africa Dialogue Series panel discussion provided a platform for robust debate and critical analysis of South Africa's political landscape, offering valuable insights into the challenges and opportunities that lie ahead in the 2024 elections and beyond.

News Archive

Cardiology Unit involved in evaluation of drug for rare genetic disease
2013-01-04

Front from the left, are: Marinda Karsten (study coordinator and registered nurse),
Laumarie de Wet (clinical technologist), Charmaine Krahenbuhl (study coordinator and radiographer),
Lorinda de Meyer (administrator), Andonia Page (study coordinator and enrolled nurse);
back Dr Gideon Visagie (sub investigator), Dr Derick Aucamp (sub investigagtor),
Prof. Hennie Theron, (principal investigator) and Dr Wilhelm Herbst (sub investigator).
Photo: Supplied
09 January 2013


The Cardiology Research Unit at the University of the Free State (UFS) contributed largely to the evaluation of the drug Juxtapid (lomitapide), which was developed by the Aegerion pharmaceutical company and approved by the FDA (Federal Drug Administration). Together with countries such as die USA, Canada and Italy, the UFS’ Unit recruited and evaluated the most patients (5 of 29) for the study since 2008.  

The drug was evaluated in persons with so-called familial homozygous hypercholesterolemia (HoFH).  

Following its approval by the FDA, Juxtapid is now a new treatment option for patients suffering from HoFH. The drug operates in a unique way which brings about dramatic improvements in cholesterol counts.  

According to Prof. Hennie Theron, Associate Professor in the Department of Cardiology at the UFS and Head of the Cardiology Contract Research Unit, HoFH is a serious, rare genetic disease which affects the function of the receptor responsible for the removal of low-density lipoprotein cholesterol (LDL-C) (“bad” cholesterol) from the body. Damage to the LDL receptor function leads to extremely high levels of blood cholesterol. HoFH patients often develop premature and progressive atherosclerosis, which is a narrowing or blockage of the arteries.  

“HoFH is a genetically transmitted disease and the most severe form of hypercholesterolemia. Patients often need a coronary artery bypass or/and aortic valve replacement before the age of 20. Mortality is extremely high and death often occurs before the third decade of life. Existing conventional cholesterol-lowering medication is unsuccessful in achieving normal target cholesterol values in this group of patients.  

“The only modality for treatment is plasmapheresis (similar to dialysis in patients with renal failure). Even with this type of therapy the results are relatively unsatisfactory because it is very expensive and the plasmapheresis has to be performed on a regular basis.  

“The drug Juxtapid, as currently evaluated, has led to a dramatic reduction in cholesterol values and normal values were achieved in several people. No existing drug is nearly as effective.  

“The drug represents a breakthrough in the treatment of familial homozygous hypercholesterolemia. The fact that it has been approved by the FDA, gives further impetus to the findings,” says Prof. Theron.  

In future further evaluation will be performed in other forms of hypocholesterolemia.  

According to Prof. Theron, the findings of the study, as well as the recent successful FDA evaluation, once again confirms the fact that the UFS’ Cardiology Contract Research Unit is doing outstanding work.  

Since its inception in 1992, the Unit has already been involved in more than 60 multi-centre, international phase 2 and 3 drug studies. Several of these studies, including the abovementioned study, really affected the way in which cardiology functions.  

The UFS’ Cardiology Contract Research Unit is being recognised nationally and internationally for its high quality of work and is constantly approached for their involvement in new studies.  

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept